Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.
about
Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspectiveChallenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations.Analysis of selected social determinants of health and their relationships with maternal health service coverage and child mortality in Vietnam.Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data.Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study.Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries.Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.Qualitative study of the feasibility of HPV vaccine delivery to young adolescent girls in Vietnam: evidence from a government-implemented demonstration program.Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countriesPerformance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.Knowledge and perception of human papilloma virus vaccine among the antenatal women in a Nigerian tertiary hospitalFeasibility of delivering HPV vaccine to girls aged 10 to 15 years in UgandaKnowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, KenyaMapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.Resources Required for Cervical Cancer Prevention in Low- and Middle-Income CountriesA cost comparison of introducing and delivering pneumococcal, rotavirus and human papillomavirus vaccines in Rwanda.Current issues in the economics of vaccination against dengue.Progress in HPV vaccination in low- and lower-middle-income countries.Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose.Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda.Human papillomavirus-associated cutaneous disease burden in human immunodeficiency virus (HIV)-positive patients: the role of human papillomavirus vaccination and a review of the literature.Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.Mothers' willingness to pay for daughters' HPV vaccine in northern Vietnam.Comparison of school based and supplemental vaccination strategies in the delivery of vaccines to 5-19 year olds in Africa - a systematic review.Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program.Knowledge, attitude, and practice on and willingness to pay for human papillomavirus vaccine: a cross-sectional study in Hanoi, Vietnam.
P2860
Q28601706-C4F5C99F-D740-41DB-8C3A-529C8C0E72D3Q30245295-D475325D-4C07-441F-99BC-B11CA084D212Q30385737-BA488C53-9610-42D0-9855-D2CE311EA2AFQ31013590-0DE9305D-BD96-4ADC-A35A-873D8C25959AQ33692293-32A27CAC-1D91-4945-BED3-5E62ADA6BA96Q33757466-D1275666-B57E-49D9-A009-7FB76E8BB7BAQ33773373-9F942F04-A763-4E24-8869-95CB06BF10CFQ33792465-CED462CC-DF99-4702-BA50-5F265D93B637Q33812737-44568145-3268-451A-8891-DD38D46A66DAQ33858092-B7EBF84F-420A-45B0-B82A-4AF5505954C8Q35041646-7F69F845-25DA-4067-8A1E-AC20DBC2C3C6Q35207337-E5A9E054-1759-44F3-AAE0-FB1EDE46ED65Q35743733-968E1A0B-132D-48C5-8AAA-654AF8351744Q35888255-9A343B21-A23E-4EFE-B8BF-94484E2FE0AEQ36154922-9A19E394-11CA-4200-A65B-9C22F82B57B9Q37710495-0BAC425C-EF42-4B00-9781-D487A6F911D3Q38661075-793C7CA7-BAE3-4029-860D-D878F20BA123Q39158741-94A86CF8-E0D9-40C7-A69F-98B38D2759D0Q42280340-C36BBEF2-11DC-40BF-94EB-E5C4FBF685F5Q45324144-898F4FB0-94B7-42DB-983A-D850BD0ED255Q45324304-A5FF09B7-B1FF-4F72-8471-20E79D3E9D87Q45324643-BDA39C5D-B131-4088-82ED-2732FB293214Q47147777-11B4541E-F38A-4529-880E-E311E01B2A00Q47586520-7FE67EE5-6753-4CD0-9A80-301C2154F46FQ48155181-CA731266-796F-48B5-A32A-ADF19EE50265Q48342158-645431E4-957B-467A-B28C-5F0A060256D1Q55177475-20A6FB51-7DF1-4D5E-903D-39DBA72F60B3
P2860
Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@en
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@nl
type
label
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@en
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@nl
prefLabel
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@en
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@nl
P2093
P2860
P921
P356
P1476
Delivery cost of human papillo ...... in Peru, Uganda and Viet Nam.
@en
P2093
Carol E Levin
D Scott LaMontagne
Diep Nguyen Thi Ngoc
John Odaga
Lysander Menezes
Maria Ana Mendoza Araujo
Swampa Sarit Rout
P2860
P304
P356
10.2471/BLT.12.113837
P407
P577
2013-06-19T00:00:00Z